Keywords: Darbepoetin alfa; Erythropoietin alfa; Stability; Orthogonal testing protocol; Glycosylation;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: erythropoietin; darbepoetin; cognitive development; very low birth weight; neurodevelopmental outcome; Darbe; Darbepoetin alfa; Epo; Erythropoietin; ESA; Erythropoiesis-stimulating agents; BASC-2; Behavioral Assessment System of Children - Second Editio
Keywords: Anaemia; CERA; chronic kidney disease; darbepoetin alfa; erythropoiesis-stimulating agents; erythropoietin; hepcidin; HIF stabilizers; iron
Keywords: Biopharmaceutical; Biosimilar; Darbepoetin alfa; Epoetin; Glycan; Glycomic characterization; Glycopeptide; Glycosylation; Mass spectrometry; Recombinant erythropoietin;
Keywords: anemia; darbepoetin alfa; erythropoiesis-stimulating agent; hemoglobin; peritoneal dialysis;
DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group
Keywords: Darbepoetin alfa; Hypoxia; Head and neck cancer; Phase 3 randomized trial;
Population Pharmacokinetics of Darbepoetin in Infants Following Single Intravenous and Subcutaneous Dosing
Keywords: pharmacokinetic/pharmacodynamic models; clinical pharmacokinetics; population pharmacokinetics; pharmacokinetics; clinical trials; Darbe; darbepoetin alfa; Epo; erythropoietin; ESA; erythropoietin-stimulating agents; HIE; hypoxic-ischemic encephalopathy;
Cloning and expression of codon-optimized recombinant darbepoetin alfa in Leishmania tarentolae T7-TR
Keywords: Darbepoetin alfa; Leishmania tarentolae; Codon optimization; Expression
Effectiveness of Darbepoetin Alfa for Chemotherapy-induced Anemia When Initiated at Hemoglobin â¤10 g/dL
Keywords: chemotherapy-induced anemia; darbepoetin alfa; hemoglobin; licensed indication; meta-analysis; transfusion;
La prise en charge de l’anémie et de ses conséquences chez les patients débutant l’hémodialyse : importance du fer intraveineux en prédialyse
Keywords: Anémie; Hémodialyse; Darbepoetin alfa; Fer intraveineux; Masse ventriculaire gaucheAnemia; Hemodialysis; Darbepoetin alfa; Iron therapy
Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: Study-level and patient-level meta-analyses
Keywords: Erythropoiesis-stimulating agents; Darbepoetin alfa; Small cell lung cancer; Non-small cell lung cancer; Meta-analysis; Mortality; Transfusion; Anemia;
Utilization and Cost in Clinical Practice of Darbepoetin Alfa and Epoetin Alfa
for Anemia Concomitant With Chemotherapy
Keywords: anemia; clinical practice patterns; darbepoetin alfa; epoetin alfa; neoplasms;
Anaemia and chronic renal failure
Keywords: anaemia; CERA; chronic kidney disease; darbepoetin alfa; erythropoietin; erythropoietin-mimetic peptides; erythropoiesis-stimulating agents; hepcidin; HIF stabilizers; iron; peginesatide
TREAT or not to treat : anémie du patient diabétique de type 2 aux stades 3 et 4 de la maladie rénale chronique
Keywords: Diabète de type 2; Anémie; Insuffisance rénale chronique; Agents stimulants l’érythropoïèse; Darbepoetin alfa; Événements cardiovasculaires; Qualité de vie; CancerType 2 diabetes; Anemia; Chronic kidney disease; Erythropoiesis-stimulating agents; Darbepoe
Faisabilité de la stratégie d’administration de la darbepoetin alfa tous les 15 jours : expérience 2005–2007 d’un centre de dialyse
Keywords: Anémie; Hémodialyse; Hémoglobine; Darbepoetin alfaAnaemia; Haemodialysis; Haemoglobin; Darbepoetin alfa
Use of latent growth curve models for assessing the effects of darbepoetin alfa on hemoglobin and fatigue
Keywords: Chemotherapy-induced anemia; Darbepoetin alfa; Latent growth models; Patient-reported fatigue
Lack of TIMP-1 increases severity of experimental autoimmune encephalomyelitis: Effects of darbepoetin alfa on TIMP-1 null and wild-type mice
Keywords: Darbepoetin alfa; Multiple sclerosis; Tissue inhibitor of metalloprotease; Experimental autoimmune encephalomyelitis
Physical and biophysical effects of polysorbate 20 and 80 on darbepoetin alfa
Keywords: polysorbate 20; polysorbate 80; darbepoetin alfa; circular dichroism; fluorescence; analytical ultracentrifugation; isothermal calorimetry; protein structure; binding; α-helix; tryptophan
Effect of darbepoetin alfa administered once monthly on maintaining hemoglobin levels in older patients with chronic kidney disease
Keywords: anemia; chronic kidney disease; darbepoetin alfa; hemoglobin; elderly;
Anaemia of chronic kidney disease
Keywords: anaemia; chronic kidney disease; darbepoetin alfa; erythropoietin; erythropoietin-mimetic peptides; erythropoiesis-stimulating agents; HIF stabilizers; iron
Darbepoetin alfa (Aranesp®) improves recognition memory in adult rats that have sustained bilateral ventral hippocampal lesions as neonates or young adults
Keywords: schizophrenia; cognition; darbepoetin alfa; novel object recognition taskEPO, erythropoietin; EPOR, erythropoietin receptor; NORT, Novel Object Recognition Task; nVH, neonatal ventral hippocampal; PD, postnatal day; VH, ventral hippocampus
Once-Monthly Darbepoetin alfa for Maintaining Hemoglobin Levels in Older Patients With Chronic Kidney Disease
Keywords: Chronic kidney disease; anemia; darbepoetin alfa; extended dosing;
Effectiveness of darbepoetin alfa versus epoetin alfa for the treatment of chemotherapy induced anemia in patients with gynecologic malignancies
Keywords: Chemotherapy induced anemia; Darbepoetin alfa; Epoetin alfa; Transfusion
Every 3 weeks dosing with darbepoetin alfa: A new paradigm in anaemia management
Keywords: Erythropoiesis-stimulating agents; Darbepoetin alfa; Chemotherapy-induced anaemia; Cancer patients; Synchronous dosing
Recent Advances in Erythropoietic Agents in Renal Anemia
Keywords: novel erythropoietic agents; anaemia; epoetin; darbepoetin alfa; biosimilars; CERA; Hematide; HIF stabilisers
Traitement par la darbepoetin alfa de l'anémie liée à l'insuffisance rénale chronique chez les patients dialysés : résultats d'une étude multicentrique française
Keywords: Darbepoetin alfa; Insuffisance rénale chronique; Dialyse; Anémie; Érythropoïétine recombinante humaineDarbepoetin alfa; Chronic renal failure; Dialysis; renal anemia; Recombinant human erythropoietinr-HuEPO (français), érythropoïétine recombinante humaine
Efficacy of Darbepoetin Alfa in Alleviating Fatigue and the Effect of Fatigue on Quality of Life in Anemic Patients with Lymphoproliferative Malignancies
Keywords: Quality of life; fatigue; anemia; lymphoproliferative malignancies; darbepoetin alfa
New EORTC guidelines for the treatment of anaemia in patients with cancer: Implications for nursing practice
Keywords: Anaemia; Cancer; Darbepoetin alfa; Epoetin alfa; Epoetin beta; Erythropoietic stimulating proteins; Fatigue
Darbepoetin Alfa Treatment for Post-Renal Transplantation Anemia During Pregnancy
Keywords: Anemia; darbepoetin alfa; kidney disease; pregnancy;
Darbepoetin alfa (Aranespâ¢) in children with chronic renal failure
Keywords: chronic renal failure; darbepoetin alfa; anemia; dialysis; pediatrics;
Glycoengineering: The effect of glycosylation on the properties of therapeutic proteins
Keywords: glycoprotein; drug design; glycosylation; darbepoetin alfa; Aranesp®; erythropoietin; serum half-life; sialic acid; stability; solubility; immunogenicity;
Treatment of Anemia with Erythropoietic Agents in Patients with Hematologic Malignancies
Keywords: Chemotherapy; Darbepoetin alfa; Epoetin alfa; Epoetin beta; Hemoglobin;
Effects of chemotherapy on endogenous erythropoietin levels and the pharmacokinetics and erythropoietic response of darbepoetin alfa: A randomised clinical trial of synchronous versus asynchronous dosing of darbepoetin alfa
Keywords: Darbepoetin alfa; Pharmacokinetics; Chemotherapy; Erythropoietin synchronous; Asynchronous;
Evaluating erythropoietic agents for the treatment of anaemia in the oncology setting
Keywords: Darbepoetin alfa; Epoetin alfa; Epoetin beta; Haemoglobin; Quality of life;
Unit dosing of darbepoetin alfa for thetreatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb, 27-week, multicenter, open-label study in Greek patients
Keywords: darbepoetin alfa; dialysis; efficacy; renal disease; rHuEPO; safety; tolerability;